An anonymized, web-based, multicenter cross-sectional survey in German-speaking countries to evaluate sex-specific differences in IBD diagnosis and further therapy

An anonymized, web-based, multicenter cross-sectional survey in German-speaking countries to evaluate sex-specific differences in IBD diagnosis and further therapy - DORO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035190

Enrollment

1000

Registered

2024-11-26

Start date

2024-11-28

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K50 K51

Interventions

Group 1: Patients with inflammatory bowel disease (IBD), single cross-sectional survey

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Previously known chronic inflammatory bowel disease (> 3 months)

Exclusion criteria

Exclusion criteria: • Illnesses that do not allow the person concerned to assess the nature and scope as well as possible consequences of the clinical trial • Lack of a confirmed IBD diagnosis

Design outcomes

Primary

Measure	Time frame
Does a sex discordance between the doctor and the patient have a negative impact on the timing of the diagnosis of IBD?	—

Secondary

Measure	Time frame
- Evaluation of a correlation between practitioner-patient sex discordance and time of therapy initiation - Evaluation of a relationship between practitioner-patient sex discordance and disease outcome (surgical interventions) - Evaluation of a correlation between patients´ sex and diagnostic latency - Evaluation of a relationship between patients´ sex and initiation of immunosuppressive therapies - Evaluation of sex-specific differences in the first symptom manifestations for IBD diagnosis - Evaluation of an association between practitioner-patient sex discordance and patient satisfaction with care - Evaluation of a relationship between practitioner-patient sex discordance and adherence to treatment	—

Measure

Time frame

- Evaluation of a correlation between practitioner-patient sex discordance and time of therapy initiation - Evaluation of a relationship between practitioner-patient sex discordance and disease outcome (surgical interventions) - Evaluation of a correlation between patients´ sex and diagnostic latency - Evaluation of a relationship between patients´ sex and initiation of immunosuppressive therapies - Evaluation of sex-specific differences in the first symptom manifestations for IBD diagnosis - Evaluation of an association between practitioner-patient sex discordance and patient satisfaction with care - Evaluation of a relationship between practitioner-patient sex discordance and adherence to treatment

—

Countries

Germany

Contacts

Public ContactMiriam Wiestler

Medizinische Hochschule Hannover

wiestler.miriam@mh-hannover.de0511-532-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026